14
Views
0
CrossRef citations to date
0
Altmetric
Literature Alerts

Literature Alerts

Pages 212-226 | Published online: 27 Sep 2008

LITERATURE ALERTS

  • Derivative spectrophotometry of bovine serum albumin microspheres containing cisplatin for pulmonary targeting. ZFIANG, M., Hou, S., GONG, T., CHEN, Y., and LIAO, G., Zhongguo Yaoxue Zazhi, 1994, 29, (6), 355–357.
  • Preliminary studies on erythromycin encapsulation in multilamellar liposomes. PANIC°, A., PIGNATELLO, R., and MAZZONE, G., Boll. Chim. Farm., 1993, 132, (10), 395–397.
  • Resorbable polymeric microspheres for drug delivery-production and simultaneous surface modification using PEO-PPO surfactants. COOMBES, A. G. A., SCHOLES, P. D., DAVIES, M. C., ILLum, L., and Davis, S. S., Biomaterials, 1994, 15, (9), 673–680.
  • Study of urosulfan microcapsules. STEPANOVA, E. F., VASILENKO, Y. K., NASIF, A. K., ANDREYEVA, I. N., and DORKINA, Y. G., Farmatsiya (Moscow), 1993, 42, (3), 13–15.
  • pH-Sensitive liposomes composed of tocopherol hemisuccinate and of phos-phatidylethanolamine including tocopherol hemisuccinate. JizoMoTo, H., KANAOKA, E., and HIRANO, K., Biochim. Biophys. Acta, 1994, 1213, (3), 343–348.
  • Liposome-associated synthetic oligonucleotides: production and in vitro release kinetics. CORTESI, R., ESPOSITO, E., GAMBARI, R., MENEGATTI, E., and NASTRUZZI, C., Pharm. Pharmacol. Lett., 1994, 3, (6), 213–216.
  • Preparation and evaluation of polylactide microspheres loaded with anti-inflammatory drug. CONTI, B., PUGLISI, G., VENTURA, C. A., GIUNCHEDI, P., and CONTE, U., Boll. Chim. Farm., 132, (10), 411–414.
  • A theoretical approach to polyhydroxy-mediated interactions between liposomes and bacteria biofilms. JONES, M. N., and KASZUBA, M., Biochem. Soc. Trans., 1994, 22, (3), 331S.
  • Optimization of the composition of liposomes for delivering thymopentin. PANIC°, A., PIGNATELLO, R., CASTELLI, F., BINDONI, M., and MAZZONE, G., Boll. Chim. Farm., 1993, (10), 415–417.
  • Analysis of the preparative variables of albumin microspheres. FORNI, F., GOLDONI, C., and BERNABEI, M. T., Boll. Chim. Farm., 1993, 132, (10), 432–435.
  • New crosslinked proteins for microsphere preparation. FORNI, F., SEGHIZZI, R., BuLGARELL I, E., CAMERONIL, R., and PIFFERI, G., Boll. Chim. Farm., 1993, 132, (10), 436–438.
  • Effects of liposome-encapsulated dichloromethylene diphosphonate on macrophage function and endotoxin-induced mortality. TSCHAIKOWSKY, K., and BRAIN, J. D., Biochim. Biophys. Ada, 1994, 1222 (3), 323–330.
  • Phase transition of lipids as a way of regulating the permeability of liposomes. SHEVCHENKO, E. V., SmisvoNA, E. Y., KAKUSHKINA, M. L., PREDVODITELEV, D. A., and ANTONOV, V. F., Farmatsiya (Moscow), 1993, 42, (3), 7–13.
  • Adriamycin-loaded albumin-heparin conjugate microspheres for intraperitoneal chemo-therapy. CREMERS, H. F. M., SEYMOUR, L. W., LAM, K., Los, G., VAN VUGT, M., KWON, G., BAE, Y. H., KIM, S. W., and FEIJEN, J., Int. J. Pharm., 1994, 110, (2), 117–125.
  • Unusual thermal stability of liposomes made from bipolar tetraether lipids. CHANG, E. L., Biochem. Biophys. Res. Commun., 1994, 202, (2), 673–679.
  • Novel pH-sensitive liposomes bearing a poly(ethyleneglycol) derivative with carboxyl groups. KONO, K., ZENITANI, K., and TAKAGISHI, T., Biochim. Biophys. Ada, 1994, 1193, (1), 1–9.
  • Lipophilic platinum complexes entrapped in liposomes: Improved stability and preserved antitumor activity with complexes containing linear alkyl carboxylato leaving groups. PEREZ. S. R., HAN, I., AL, B. S., and KHOKHAR, A. R., Cancer Chemother. Pharmacol., 1994, 33, (5), 378–384.
  • Controlled release from liposome of long-chain polymerizable diacetylenic phosphocholine and a short-chain saturated phospholipid. MARKOWITZ, M. A., CHANG, E. L., and SINGH, A., ACS Symp. Ser., 1994, 556, (Diagnostic Biosensor Polymers), 264–275.
  • Biodegradable microspheres containing a colchicine analog inhibit DNA synthesis in vascular smooth muscle cells. MARCH, K. L., MOHANRAJ, S., Ho, P. P. K., WILENSKY, R. L., and HATHAWAY, D. R., Circulation, 1994, 89, (5), 1929–1933.
  • Pharmacokinetics, tissue distribution, and toxicology of tretinoin incorporated in liposomes. LOPEZ, B. G., ROSENBLUM, M., SADEGHI, T., and MEHTA, K. y. Liposome Res., 1994, 689–700.
  • Preclinical and clinical experience with liposome-encapsulated mitoxantrone. SCHWENDENER, R. A., HORBER, D. H., RENTSCH, K., HANSELER, E., PESTALOZZI, B., and SAUTER, C.3. Liposome Res., 1994, 605–639. 0265-2048/95 $10-00 0 1995 Taylor & Francis Ltd.
  • Effect of MTP-PE liposomes and interleukin-7 on induction of antibody and cell-mediated immune responses to a recombinant HP/-envelope protein. Bui, T., DYKERS, T., Hu, S. L., FALTYNEK, C. R., and Ho, R. J. Y., I. Acquired Immune Defic. Syndr., 1994, 7, (8), 799–806.
  • Modulation of multidrug resistance in cancer cells by liposome-encapsulated doxorubicin. RAHMAN, A., J. Liposome Res., 1994, 575–604.
  • Liposomal anthracyclines: facing the clinical challenge. GABIZON, A. A., J. Liposome Res., 1994, 445–454.
  • Pulsatile release from microencapsulated liposomes. COHEN, S., and LANGER, R., y. Liposome Res., 1994, 349–360.
  • Liposomes in leather dyeing: stability of dye-liposome systems and applications. DE LA MAZA, A., MARSAI,, A., COT, J., MANICH, A., and PARRA, J. L., J. Am. Leather Chem. Assoc., 1992, 87, (12), 459–465.
  • The hysteretic growth of microspherical particles consisting of thermal heterocomplex molecules from amino acids. SAKURAZAWA, S., HONDA, H., ImAi, E., and MATSUNO, K., Viva Origin°, 1994, 22, (2), 81–87.
  • Characterization of human immunodeficiency virus type 1 gp120 binding to liposomes containing galactosylceramide. LONG, D., BERSON, J. F., COOK, D. G., and Doms, R. W., J. Virol., 1994, 68, (9), 5890–5898.
  • Effects of microsomes and liposomes on glutathione transferase-catalyzed conjugation of benzo(a)pyrene diol epoxide with glutathione. Oot, S. G., JERNSTROEM, B., and AHOKAS, J., Chem. Biol. Interact., 1994, 91, (1), 15–27.
  • Preparation, properties and the effects of free and liposomal tobramycin on siderophore production by Pseudomonas aeruginosa. POYNER, E. A., ALPAR, H. O., and BROWN, M. R.Antimicrob. Chemother., 1994, 34, (1), 43–52.
  • Synthesis, characterization, and use of immobilized polyacrolein microspheres in diagnos-tics: a model determination of alpha 1-antitrypsin in human serum. DOLITZKY, Y., STURCHAK, S., NIZAN, B., SELA, B. A., and MARCEL, S., Anal. Biochem., 1994, 220, (2), 257–267.
  • Determining the location of hydrophobic spin traps within liposomes. STRUL, G., GOTTLIEB, H. E., FRIMER, A. A., and WEINER, L., y. Chem. Soc., Perkin. Trans., 1994, 2, (6), 1229–1232.
  • Photoinduced fusion of liposomes. BENNETT, D. E., and BRIEN, D. F., y. Am. Chem. Soc., 1994, 116, (17), 7933–7934.
  • Effects of cerebroside and cholesterol on the reconstitution of tonoplast H + -ATPase purified from mung bean (Vigna radiata L) hypocotyls in liposomes. YAMANISHI, H., and KASAMO, K., Plant Cell. Physiol., 1994, 35, (4), 655–663.
  • An NMR study of pyridine associated with DMPC liposomes and magnetically ordered DMPC-surfactant mixed micelles. HENDERSON, J. M., IANNUCCI, R. M., and PETERSHEIM, M., Biophys. 1., 1994, 67, (1), 238–249.
  • A simplified model for liposome aggregation and fusion. ANNESINI, M. C., Di, M. L., TRAZZA, C., and MOSSA, G., Y. Liposome Res., 1993, 3, (3), 687–695.
  • Liposome reconstitution of native or reduced and alitylated transferring receptor. Di, G. A., ANDREA, D. G., SALETTI, M. A., DINI, L., LENTINI, A., ALESSANDRO, D. A. M., and ORATORE, A.,.7. Liposome Res., 1993, 3, (3), 679–685.
  • Liposomes from mammalian liver mitochondria are more polyunsaturated and leakier to protons than those from reptiles. BRAND, M. D., COUTURE, P., and HULBERT, A. J., Comp. Biochem. Physiol. B: Biochem. Mol. Biol., 1994, 108B, (2), 181–188.
  • Self-reproduction of micelles and liposomes and the transition to life. Luisi, P. L., VONMONT, B. P. A., FRESTA, M., WALDE, P., and WEHRLI, E.J. Liposome Res., 1993, 3, (3), 631–638.
  • Physicochemical damage to liposomal membrane induced by iron- or copper-mediated lipid peroxidation. ZHANG, D., YASUDA, T., Yu, Y., and OKADA, S., Acta Med. Okayama, 1994, 48, (3), 131–136.
  • Improvement of impaired brain monoamine metabolism by the cognition-enhancing agent nefiracetam after microsphere-induced cerebral embolism in rats. WATABE, S., TANI GUCHI, K., and KOJIMA, H., Arzneim-Forsch., 1994, 44, (2a), 195–198.
  • Antitumor effect of interleukin-2 entrapped in liposomes on murine renal cell carcinoma. OYA, M., Keiol. Med., 1994, (1), 37–44.
  • Nonlocal response of size-quantized excitons in a semiconductor microsphere. CHO, K., NistiloA, M., OHFUTI, Y., and BELLEGUIE, L.,Lumin., 1994, 60–61. 330–233.
  • Comparison of cell proliferation and toxicity assays using two cationic liposomes. LAPPALAINEN, K., JAASKELAINEN, 1., SYRJANEN, K., URTTI, A., and SYRJANEN, S., Pharm. Res., 1994, 11, (8), 1127–1131.
  • In vivo and electron microscopic studies of rat liver after intravenous injection of polyamino acid microspheres. Li, C., MCCUSKEY, P., KAN, Z., YANG, D. J., WRIGHT, K. C., and WALLACE, S.,Biomed. Mater. Res., 1994, 28, (8), 881–890.
  • Preparation and temperature-controlled drug-release behaviour of graft copolymer PAA-g-PIPA microspheres. Li, X., YAN, C., and LIAO, Q., Gaofenzi Xuebao, 1994, (2), 156–161.
  • Tetrandrine delivery to the lung: the optimization of albumin microsphere preparation by central composite design. ZENG, X. M., MARTIN, G. P., and MARRIOTT, C., Int. J. Pharm., 1994, 109, (2), 135–145.
  • Transmitter-loaded polymeric microspheres induce regrowth of dopaminergic nerve terminals in striata of rats with 6-OH-DA-induced Parkinsonism. McRAE, A., and DAHLSTROEM, A., Neurochem. Int., 1994, 25, (1), 27–33.
  • Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers. OKADA, H., DOKEN, Y., OGAWA, Y., and TOGUCHI, H., Pharm. Res., 1994, 11,(8), 1143–1147.
  • Microencapsulation of tissue cultures. Application in biotechnology, and medicine. BUGARSKI, B., JovANovic, G., VoKovic, D. V., and VUNJAK, N. G., Hem. Ind., 1993, 47, (11–12), 151–157.
  • Liposomes modified by monoclonal antibody and targeting in vitro. Hou, X., NING, B., GAO, X., and Li, X., Zhongguo Yaoxue Zazhi., 1994, 29, (5), 282–284.
  • Hematological, biochemical, anatomical and pathological studies concerning the administra-tion of liposomes containing copper acetylsalicylate on rabbit skin. Stud. Cercet. Biochim., 1993, 36, (1-2), 19–24.
  • Studies on cisplatin albumin microspheres for lung targeting. ZHANG, M., Hou, S. X., GONG, T., CHENG, Y. H., and LIAO, G. T., Yaoxue Xuebao, 1994, 29, (5), 380–386.
  • Physicochemical properties and their influencing factors of microencapsulation of sulfadi-azine with spray dry process. MAO, L., and ZHANG, R. H., Zhongguo Yiyao Gongye Zazhi, 1994, 25, (3), 114–117.
  • Preparation and characteristics of adriamycin magnetic gelatin microspheres. Wu, C., B., HE, S. M., GAO, W. W., and WEI, S. L., Zhongguo Yiyao Gongye Zazhi, 1994, 25, (2), 63–66.
  • Experimental study on controlled-release indomethacin microcapsule hollow suppositories. ZENG, R., JING, L., SUN, W., LIU, Y., WANG, J., and HUANG, J., Zhongguo Yiyuan Yaoxue Zazhi, 1994, 14, (3), 103–106.
  • Encapsulation of a quinolone in liposomes. Location, and effect on lipid bilayers. MONTERO, M. T., CARREFtA, I., and HERNANDEZ, B. J., J. Microencapsulation, 1994, 11, (4), 423–430.
  • Controlled drug delivery to the joints by enzymically degradable microspheres. BROWN, K. E., SHAO, W., BATHON, J., and LEONG, K. W., Mater. Res. Soc. Symp. Proc., 1994, 331 (Biomaterials for Drug and Cell Delivery), 73–78.
  • Delivery of interferon to intracellular pathways by encapsulation of interferon into multilamellar liposomes is independent of the status of interferon receptors. KILLION, J. J., FISHBECK, R., BAR, E. M., and CHERNAJOVSKY, Y., Cytokine, 1994, 6, (4), 443–449.
  • Trapping of dextran-coated colloids in liposomes by transient binding to aminophospholipid: preparation of ferrosomes. BOGDANOV, A. A. JR, MARTIN, C., WEISSLEDER, R., and BRADY, T. J., Biochim. Biophys. Acta, 1994, 1193, (1), 212–218.
  • Phase transition temperature reduction and glass formation in dehydroprotected lyophilized liposomes. MOBLEY, W. C., and SCHREIER, H., J. Controlled Release, 1994, 31, (1), 73–87.
  • Influence of physico-chemical parameters on the release of hydrocortisone acetate from albumin microspheres. ORIENTI, I., COPPOLA, A., GIANASI, E., and ZECCHI, V., J. Controlled Release, 1994, 31, (1), 61–71.
  • Synthesis of albumin-dextran sulfate microspheres possessing favorable loading and release characteristics for the anticancer drug doxorubicin. CHEN, Y McCuLLocH, R. K., and GRAY, B. N., J. Controlled Release, 1994, 31, (1), 49–54.
  • Effect of temperature on mechanisms of drug release and matrix degradation of poly(D, L-lactide) microspheres. Aso, Y., YOSHIOKA, S., Li, W. P. A., and TERAO, T., J. Controlled Release, 1994, 31, (1), 33–39.
  • Preparation of liposomal-encapsulated SOD and serum pharmacokinetics after intravenous administration. HIRATA, I., TANAKA, S., ASHIHAFtA, M., TSUKAMOTO, S., SUGIOKA, N., KiSHIMOTO, H., YOSHIKAWA, T., TANIGAWA, T., and NAITO, Y. etal., Byoin Yakugaku, 1994,20, (1), 1–9.
  • Pharmaceutics of microspheres containing levonorgestrel and iturface characteristics. WANG, S. H., HAN, J. W., LIN, F., ZHOU, X. F., and SHEN, W. Z., Zhongguo Yiyao Gongye Zazhi, 1994, 25, (3), 109–121.
  • Identification of vesicle properties that enhance the antitumor activity of liposomal vincristine against murine L1210 leukemia. MAYER, L. D., NAYAR, R., THIES, R. L., BOMAN, N. L., CuLus, P. R., and BALLY, M. B., Cancer Chemother. Pharmacol., 1993, 33, (1), 17–24.
  • Cationic liposomes mediated delivery of antisense oligonucleotides targeted to HPV 16 E7 mRNA in CaSki cells. LAPPALAINEN, K., URT'TI, A., JAASKELAINEN, I., SYRJANEN, K., and SYRJANEN, S., Antiviral Res., 1994, 23, (2), 119–130.
  • Long-circulating (sterically stabilized) liposomes for targeted drug delivery. ALLEN, T. M., Trends Pharmacol. Sci., 1994, 15, (7), 215–220.
  • Some aspects of production and application of microencapsulated chemical products. VILESOVA, M. S., Zh. Prikl. Khim. (S. Peterburg), 1994, 67, (1), 79–83.
  • Digestion and assimilation of protein by Mytilus trossulus (Bivalvia: Mollusca) fed mixed carbohydrate/protein microcapsules. KREEGER, D. A., and LANGDON, C. J., Mar. Biol. (Berlin), 1994, 118, (3), 479–488.
  • Physical and biochemical characterization of Albunex, a new ultrasound contrast agent consisting of air-filled albumin microspheres suspended in a solution of human albumin. CHRISTIANSEN, C., KRYVI, H., SONTUM, P. C., and SKOTLAND, T., Biotechnol. Appl. Biochem., 1994, 19, (3), 307–320.
  • In vivo measurement of oxygen concentration using sonochemically synthesized micro-spheres. Ltu, K. J., GRINSTAFF, M. W., JIANG, J., SUSLICK, K. S., SWARTZ, H. M., and WANG, W., Biophys. y., 1994, 67, (2), 896–901.
  • Water soluble C60-liposome and the biological effect of C60 to human cervix cancer cells. Li, W., QIAN, K., HUANG, W., ZHANG, X., and CHEN, W., Chin. Phys. Lett., 1994, 11, (4), 207–210.
  • Na3(B201117NH3): Synthesis and liposomal delivery to murine tumors. FEAKES, D. A., SHELLY, K., KNOHLER, C. B., and HAWTHORNE, M. F., Proc. Natl. Acad. Sci, USA, 1994, 91, (8), 3029–3330.
  • Activity of phospholipase A2 on a fluorescent substrate incorporated into non-hydrolyzable phospholipid liposomes. FERNANDEZ, M. S., and JUAREZ, J. A., Biochim. Biophys. Acta, 1994, 1192, (1), 132–142.
  • Liposomal and mitochondrial cytochrome oxidase display similar bioenergetic properties. SARII, P., ANTONINI, G., MALATESTA, F., D'ITRI, E., GIUFFRE, A., NICOLETTI, F., and BRUNORI, M., y. Liposome Res., 1993, 3, (3), 589–598.
  • Flocculation of egg-phosphatidylcholine liposomes under drift flow brought on by gravity. MATSUMURA, H., Chem. Lett., 1994, (5), 893–896.
  • Binding of synapsin I to synaptic vesicles: clues from the study of its interactions with liposomes. BENFENATI, F., VALTORTA, F., NEYROZ, P., and GREENGARD, P., J. Liposome Res., 1993, 3, (3), 599–609.
  • Influence of charge, charge distribution, and hydrophobicity on the transport of short model peptides into liposomes in response to transmembrane pH gradients. CHAKRABARTI, A. C., CLARK, L. I., and BULLIS, P. R., Biochemistry, 1994, 33, (28), 8479–8485.
  • The increased efficacy and decreased nephrotoxicity of a'cyclosporin liposome. FREISE, C. E., Liu, T., HONG, K., OSORIO, R. W., PAPAHADJOPOULOS, D., FERRELL, L., ASCHER, N. L., and ROBERTS, J. P., Transplantation, 1994, 57, (6), 928–932.
  • Chemoprevention and therapy of mouse mammary carcinomas with doxorubicin encapsu-lated in sterically stabilized liposomes. VAAGE, J., DONOVAN, D., LOFTUS, T., ABRA, R., WORKING, P., and HUANG, A., Cancer (Philadelphia), 1994, 73, (9), 2366–2371.
  • Comparison of the activity of free and lipsomal amphotericin B in vitro and in a model of systemic and localized murine candidiasis. PAHLS, S., and SCHAFFNER, A., J. Infect. Dis., 1994, 169, (5), 1057–1061.
  • High-order resonance structures in a Nd-doped glass microsphere. LUE, B., WANG, Y., Li, Y., and LIG, Y., Opt. Commun., 1994, 108, (1-3), 13–16.
  • Ninth International Symposium of Microencapsulation, Hacettepe University, Ankara, 13–15 September 1993. KAS, H. S., and HINCAL, A. A. (Eds). Ed. Sante, Paris, France, 1994, 228 pp.
  • Liposomes: From Physics to Applications. LASIE, D. D., Amsterdam: Elsevier, 1993, 580 pp. Free and microencapsulated adrenal cortical cells produce similar cortisol responses when stimulated by ACTH: An in vitro study. ABOBAKR, A. M., Int. J. Art if. Organs, 1994, 17, (3), 171–174.
  • Sustained suppression of the pituitary-gonadal axis by leuprorelin three-month depot microspheres in rats and dogs. OKADA, H., DoKEN, Y., OGAWA, Y., and TOGUCHI, H., Pharm. Res., 1994, 11, (8), 1199–1203.
  • Microencapsulation by coacervation of poly(lactide-co-glycolide). III. Characterization of the final microspheres. NIHANT, N., STASSEN, S., GFtANDFILS, C., JEROME, R., TEYSSIE, PH., and GorFINET, G., Polym. Int., 1994, 34, (3), 289–299.
  • Syntheses of novel galactosyl ligands for liposomes and their accumulation in the rat liver. SASAKI, A., MURAHASHI, N., YAMADA, H., and MORIKAWA, A., Biol. Pharm. Bull., 1994, 17, (5), 680–685.
  • Enhanced delivery and antitumor activity of doxorubicin using long-circulating thermosensi-dve liposomes containing amphipathic polyethylene glycol in combination with local hyperthermia. UNEZAKI, S., MARUYAMA, K., TAKAHASHI, N., KOYAMA, M., YUDA, T., SUGINAKA, A., and IWATSURU, M., Pharm. Res., 1994, 11,(8), 1180–1185.
  • Preparation and properties of lipsomes stabilized with Pluronic F-68. SASAKI, I., SUZUKI, T., F., and OGATA, H., Yukagaku, 1994, 43, (7), 567–573.
  • Studies on the release of tinidazole from polyacrylate microspheres. LAMBOV, N., TSANKOV, S., GRINBERG, M., and MINKOV, E., Pharmazie, 1994, 49, (6), 438–440.
  • Alginate microspheres of microbial spores and viable cells of Bacillus subtilis. PEPELJNJAK, S., FILIPOVIC, G. J., and JALSENJAK, V., Pharmazie, 1994, 49, (6), 436–437.
  • The influence of biodegradable microcapsule formulations on the controlled release of a protein. SAH, H. K., TODDYWALA, R. and CHIEN, Y. W., y. Controlled Release, 1994, 30, (3), 201–211.
  • Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. YUAN, F., LEUNIG, M., HUANG, S. K., BERK, D. A., PAPAHADJOPOULOS, D., and JAIN, R. K., Cancer Res., 1994, 54, (13), 3352–3356.
  • Degradation of poly(D, I.-lactic acid) microspheres: effect of molecular weight. PARK, T. G., y. Controlled Release, 1994, 30, (2), 161–173.
  • Formulation and in vitro release study on poly(DL-lactide) microspheres containing hydrophilic compounds: glycine hornopeptides. PRADHAN, R. S., and VASAVADA, R. C., J. Controlled Release, 1994, 30, (2), 143–154.
  • The protective effect of free and membrane-bound cryoprotectants during freezing and freeze-drying of liposomes. AUSBORN, M., SCHREIER, H., BREZESINSKI, G., FABIAN, H., MEYER, H. W., and NUHN, P., J. Controlled Release, 1994, 30, (2), 105–116.
  • Selective uptake of liposomes containing lactose mono-fatty acid derivatives by hepatic parenchymal cells. YAMAUCHI, H., KIKUCHI, H., SAWADA, M., TomIKAWA, M., and HIROTA, S., J. Microencapsulation, 1994, 11, (3), 287–296.
  • An experimental study of lactic acid oligomer microspheres incorporating cisplatin administered intraperitoneally. ANON., Kyoto-furitsu Ika Daigaku Zasshi, 1994, 103, (3), 339–348.
  • Liposomes attached to monoclonal antibody and their association with stomach cancer cells. WANG, B., and YANG, H., Shenyang Yaoxueyuan Xuebao, 1994, 11, (1), 17–20.
  • Enhancement of rotavirus immunogenicity by microencapsulation. OFFIT, P. A., KHOURY, C. A., MOSER, C.A., CLARK, H. F., Kim, J. E., and SPEAKER, T. J., Virology, 1994, 203, (1), 134–143.
  • The immunodominant peptide from listeriolysin in Quil A liposomes vaccinates CD8 + cytolytic T cells and confers protection to infection. LIPFORD, G. B., LEHN, N., BAUER, S., HEEG, K., and WAGNER, H., Immunol. Lett., 1994, 40, (2), 101–104.
  • Control of pore size and morphology in collagen microspheres. MAFFIA, G. J., Mater. Res. Soc. Symp. Proc., 1994, 331, (Biomaterials for Drug and Cell Delivery), 53–58.
  • Alkalinity of finely divided glass micropheres of various chemical composition. STETSENKO, V. Y., and YUSHCHENKO, V. V., Fiz. Khim. Stekla, 1993, 19, (6), 856–863.
  • Synthesis of nanometer glass particles by pulsed-laser ablation of microspheres. JUANG, C. B., CAI, H., BECKER, M. F., KETO, J. W., and BROCK, J. R., Appl. Phys. Lett., 1994, 65, (1), 40–42.
  • Mechanical properties and microstructure of 6061 aluminum alloy matrix composite reinforced with alumina microspheres. WANG, J., FURUKAWA, M., HORITA, Z., NEMOTO, M., MA, Y., and LANGDON, T. G., Keikinzoku, 1994, 44, (5), 286–291.
  • Microspheres for on-board hydrogen storage. DURET, B., and SAUDIN, A., Int. J. Hydrogen Energy, 1994, 19, (9), 757–764.
  • Fundamentals of hollow microsphere-microcylinder technology. MERKULEV, Y. A., Tr. Fiz. Inst. im P N Lebedeva, Ross. Akad. Nauk., 1992, 220, 113–178.
  • Effect of substrate structure on release performance of lauryl alcohol microsphere. CHEN, J., CHEN, Y., and Li, Y., Mo Kexue Yu jishu, 1993, 13, (1), 64–68.
  • Secretion pattern of the rat liver macrophage population following activation with liposomal muramyl dipeptide in vivo and in vitro. HOEDEMAKERS, R. M. J., MORSELT, H. W. M., SCHERPHOF, G. L., and DAEMEN, T., y. Immunother. Emphasis Tumor Immunol., 1994, 15, (4), 265–272.
  • Quantitative determination of C3 fragments on the liposomal surface with anti-human C3 monoclonal antibodies. 1SHIDA, T., SHINOHARA, M., IWATA, F., OHMOTO, Y., and KIWADA, H., Drug Delivery Syst., 1994, 9, (1), 25–30.
  • Es-vivo sensors; microencapsulation of enzyme layer in biosensors. TRELOAR, P. H., HIGSON, S. P. J., DESAI, M. A., CHRISTIE, I. M., GHOSH, S., ROSENBERG. M. F., REDDY, S. M., JONES, M. N., and VADGAMA, P. M., NATO ASI Ser, Ser E, 1993, 252, (Uses of Immobilized Biological Compounds), 131–140.
  • Synthesis and biological evaluation of a series of new germanium phthalocyanines incorporated into liposomes. Part II: Biological evaluation. SCHIEWECK, K., CAPRARO, H. G., ISELE, U., BATT, E., OCHSNER, M., VAN HOOGEVEST, P., and LOVE, W. G., Proc. SPIE-Int. Soc. Opt. Eng., 1994, 2078, (Photodynamic therapy of Cancer), 165–170.
  • Synthesis and biological evaluation of a series of new germanium phthalocyanines incorporated into liposomes. Part I: Chemistry. CAPRARO, H. G., SCHIEWECK, K., HILFIKER, R., OCHSNER, M., ISELE, U., VAN HOOGEVEST, P., NAEF, R., and BAUMANN, M., Proc. SPIE-Int. Soc. opt. Eng., 1994, 2078, (Photodynamic Therapy of Cancer), 158–164.
  • Biodistributi on and imaging studies of technetium-99m-labeled liposomes in rats with focal infection. GOINS, B., KLIPPER, R., RUDOLPH, A. S., CLIFF, R. O., BLUMHARDT, R., and PHILLIPS, W. T., J. Nucl. Med., 1994, 34, (12), 2160–2108.
  • Synthesis of polymeric microcapsule arrays and their use for enzyme immobilization. PARTHASARATHY, R., and MARTIN, C. R., Nature (London), 1994, 369, (6478), 298–301.
  • Kinetics of spreading at the air-water interface of dioleoylphosphatidylcholine liposomes influenced by photodynamic lipid peroxidation. PANAIOTOV, I., PROUST, J. E., RANEVA, V., and IVANOVA, T., Thin Solid Films, 1994, 244, (1-2), 845–851.
  • Interactions of the pyrethroid insecticide allethrin with liposomes. MOYA, Q. M. R., MUNOZ, D. E., and VIDAL., C. J., Arch. Biochem. Biophys., 1994, 312, (1), 95–100.
  • Immunoassay devices for extra-laboratory measurements of toxic chemicals based on capillary migration and liposome amplification. DURST, R. A., SIEBERT, S. T. A., ROBERTS, M. A., and REEVES, S. G., NATO AS Ser., Ser. E, 1994, 252, (Uses of Immobilized Biological Compounds), 421–432.
  • Beneficial effects of myristic, stearic or oleic acid as part of lipsomes on experimental infection and antitumor effect in a murine model. GALDIERO, F., CARRATELLI, C. R., Nuzzo, I., BENTIVOGLIO, C., MARTINO, L., D., GORGA, F., FOLGORE, A., and GALDIERO, M., Life Sci., 1994, 55, (7), 499–509.
  • Target therapy on nude mice bearing ovarian carcinoma and ascites by monoclonal antibody C0C166-9 conjugated with liposome-entrapped adriamycin. Li, W., Q1AN, H., LIN, W., WANG, J., Li, M., and ZHANG, C., Beijing Yike Daxue Xuebao, 1993, 25, (5), 318–320.
  • Tumor cell binding and induction of endothelial cell tumoricidal activity in vitro by muramyl dipeptide is enhanced by lipsomal encapsulation. PHILLIPS, N. C., STEWART, P. J., and WANG, P., J. Immunother. Emphasis Tumor Immunol., 1994, 15, (3), 185–193.
  • Liposomes: Technological, Biological and Pharmacological Aspects. DELATTRE, J., and COUVREUR, P., Paris: Tec ei Doc Lavoisier, 1993, 266 pp.
  • Microspheres of 5-fluorouracil using poly(DL-lactic acid): in vitro release properties and distribution in mice after i.v. administration. CIFCI, K., HINCAL, A. A., KAS, H. S., ERCAN, M. T., and RUACAN, S., Eur. y. Pharm. Sci., 1994, 1, (5), 249–258.
  • Incorporation and release of chemically intact mitomycin C from albumin microspheres: a high-performance liquid chromatography evaluation. ALLAN, L., CUMMINGS, J., WII,LMOTT, N., WHATELEY, T. L., and SMYTH, J. F., 9'. Drug Targeting, 1994, 1, (4), 317–323.
  • Preparation and characterization of liposomes incorporating hydrophobic poly(amino acid)s with different secondary structure. SHIBATA, A., NAKAJIMA, K., UEN0, S., and YAMASHITA, T., Chem. Phar. Bull., 1994, 42, (5), 1151–1153.
  • Preparation and in vitro evaluation of poly(lactic acid) microspheres containing cormofur. MABUCHI, K., NAKAYAMA, A., and IwAmoTo, K., Yakuzaigaku, 1994, 54, (1), 42–48.
  • Preparation and evaluation of ion-exchange cross-linked chitosan microspheres. Hou, W., MIYAZAKI, S., and TAKADA, M., Yakuzaigaku, 1994, 54, (1), 10–18.
  • Preparation of polylactic acid microspheres containing 5-fluorouracil. YAO, F., GAO, Y XIAO, D., SHEN, Y ., and ZHENG, A., Zhongguo Yiyao Gongye Zazhi, 1993, 24, (11), 489–491.
  • Effect of the solvent-non-solvent pairs on the surface morphology and release behaviour of ethyl cellulose microcapsules prepared by non-solvent-addition phase separation method. Wu, J. C., Su, S. G., SHYU, S. S., and CHEN, H. J. Microencapsulation, 1994, 11, (3), 297–308.
  • Fluoresence resonance energy transfer measurements as a tool to detect fusion and drug exchange in liposomal suspensions. HI LEI KER, R., WILLI, A., ISELE, U., and VAN HOOGEVEST, P., Proc. SPIE-Int. Soc. opt. Eng., 1994, 2078, (Photodynamic Therapy of Cancer), 467–470.
  • Comparative in vitro evaluation of cumulative release of the urinary antiseptics nalidixic acid, pipemidic acid, cinoxacin, and norfloxacin from white beeswax microspheres. GIANNOLA, L. I., DE CARO, V., and Di STEFANO, V., Drug Dev. Ind. Pharm., 1994, 20, (14), 2285–2297.
  • Preferential uptake of lactosylceramide-bearing dipalmitoylphosphatidylcholine-liposomes into liver: role of membrane fluidity. YOSHIOKA, S., IMAEDA, N., OKANO, Y MIZUKAMI, Y., and KATAGIRI, V., Biol. Pharm. Bull., 1994, 17, (5), 640–644.
  • Protein kinase C inhibitors suppress LPS-induced TNF production in alveolar macrophages and in whole blood: the role of encapsulation into liposomes. TSCHA1KOWSKY, K., Biochim. Biophys. Acta, 1994, 1222, (1), 113–121.
  • Controlled release of triamterene from poly(DL-lactide-co-glycolide) microspheres. OUELLETTE, A. D., and PEPPAS, N. A., Mater. Res. Soc. Symp. Proc., 1994, 331, (Biomaterials for Drug and Cell Delivery), 91–96.
  • Study of drug delivery into the cytoplasm with targeted liposomes. SUZUKI, H., LESERMAN, L., MACHY, P., MATSUMOTO, S., and TADAKUMA, T., Drug Delivery Syst., 1994, 9, (2), 105–111.
  • Drug delivery system using long-circulating thermosensitive liposomes in combination with local hyperthermia. UNEZAKI, S., MARUYAMA, K., TAKAHASHI, N., and IWATSURU, M., Drug Delivery Syst., 1994, 9, (2), 97–103.
  • Preparation and evaluation of microspheres of diclofenac sodium. RANI, K. N. S., Go u NDALKAR, A. G., and PRAKASAM, K., Indian Y. Pharm. Sci., 1994, 56, (2), 45–50.
  • Comparison of absorption of aqueous lidocaine and liposome lidocaine following topical application on rabbit vessels. Hou, S. M., and Yu, H. Y., .7. Orthop. Res., 1994, 12, (2), 294–297.
  • Stability study of drug-loaded proteinoid microsphere formulations during freeze-drying. MA, X., SANTIAGO, N., CHEN, Y. S., CHAUDHARY, K., MILSTEIN, S. J., and BAUGHMAN, R. A.,Y. Drug Targeting, 1994, 2, (1), 9–21.
  • Ammonium sulfate gradients for efficient and stable remote loading of amphipathic weak bases into liposomes and ligandoliposomes. BOLOTIN, E. M., COHEN, R., BAR, L. K., EMANUEL, N., NINIO, S., LASIC, D. D., and BARENHOLZ, Y., J. Liposome Res., 1994, 455–479.
  • The effect of dosing volume on the disposition of cyclosporin A in hairless mouse skin after topical application of a nonionic liposomal formualtion: an in vitro diffusion study. NIEMIEC, S. M., Hu, Z., RAMACHANDRAN, C., WALLACH, D. F. H., and WEINER, N., STP Pharma. Sci., 1994, 4, (2), 145–149.
  • Liposomes as a carrier for oral administration of insulin: effect of formulation factors. CHOUDHARI, K. B., LABHASETWAR, V., and DORLE, A. K., Y. Microencapsulation, 1994, 11, (3), 319–325.
  • Liposomes as carriers of different new lipophilic antitumor drugs: a preliminary report. SAMPEDRO, F., PARTIKA, J., SANTALO, P., MOLINS, P. A. M., BONAI„ J., and PEREZ, S. R., Y. Microencapsulation, 1994, 11, (3), 309–318.
  • Topical liposome system bearing local anesthetic lignocaine: preparation and evaluation. SHARMA, B. B., JAIN, S. K., and VYAS, S. P., y. Microencapsulation, 1994, 11, (3), 279–286.
  • Phagocytosis and degradation of human serum albumin microspheres and nanoparticles in human macrophages. SCHAEFER, V., VON BRIESEN, H., RUEBSAMEN, WAIGMANN, H., STEFFAN, A. M., ROYER, C., and KREUTER, J., J. Microencapsulation, 1994, 11, (3), 261–269.
  • Production and in vitro evaluation of gelatin microspheres containing an antitumor tetra-amidine. NASTRUZZI, C., PASTESINI, C., CORTES, R., ESPOSITO, E., GAMBARI, R., and MENEGATTI, E., y. Microencapsulation, 1994, 11, (3), 249–260.
  • Liposomal N, N, N-trimethylsphingosine (TMS) as an inhibitor of B16 melanoma cell growth and metastasis with reduced toxicity and enhanced drug efficacy compared to free TMS: cell membrane signaling as a target in cancer therapy III. PARK, Y. S., HAKOMORI, S., KAWA, S., RUAN, F., and IGARASHI, Y., Cancer Res., 1994, 54, (8), 2213–2217.
  • Characterization and tissue distribution of liposomes containing lactose mono-fatty acid derivatives. YAMAUCHI, H., KIKUCHI, H., SAWADA, M., TOMIKAWA, M., and HIROTA, S., J. Microencapsulation, 1994, 11, (2), 179–188.
  • Preparation and characterization of liposome-encapsulated hemoglobin by freeze-thaw method. Liu, L., and YONETANI, T., Y. Microencapsulation, 1994, 11, (4), 409–421.
  • Inclusion of ganglioside GM1 into liposome encapsulated hemoglobin does not extend circulation persistence at clinically relevant doses. Got NS, B. LIGLER, F. S., and Ru DOLPH, A. S., Artif. Cells, Blood Substitutes, Immobilization Biotechnol., 1994, 22, (1), 9–25.
  • Oral immunization of humans with dehydrated liposomes containing Streptococcus mutans glucosyltransferase induces salivary immunoglobulin A2 antibody responses. CHILDERS, N. K., ZHANG, S. S., and MICHALEK, S. M., Oral Microbiol. Immunol., 1994, 9, (3), 146–153.
  • Double-walled microspheres for drug delivery. PEKAREK, K. J., JACOB, J. S., and MATHIOWITZ, E., Mater. Res. Soc. Symp. Proc., 1994, 331 (Biomaterials for Drug and Cell Delivery), 97–101.
  • Use and stability of liposomes in dermatological preparations. NASTRUZZI, C., ESPOSITO, E., MENEGATTI, E., and WALDE, P., J. Appl. Cosmetol., 1993, 11, (3), 77–91.
  • Unsaponifiable liposomes from olive oil. Quantitative determination of liposome roles. MASSERA, A. M., and ESTE, R., Cosmet. News, 1993, 16, (93), 401–407.
  • Effects of suspension crosslinking reacting conditions on the sizes of starch microspheres. Yu, J., and Liu, J., StarchlStaerke, 1994, 46, (7), 252–255.
  • Experimental observations in the preparation of microsphere polymer dispersions. CHANG, C. S., and STOWELL, J. K., Tappi. J., 1993, 76, (8), 151–156.
  • Liposome-like particles isolated from human atherosclerotic plaques are structurally and compositionally similar to surface remnants of triglyceride-rich lipoproteins. CHUNG, B. H., TALLIS, G., YALAMOORI, V., ANANTHARAMAIAH, G. M., and SEGREST, J. P., Arterioscler. Thromb., 1994, 14, (4), 422–435.
  • Purification of fusion proteins using affinity microspheres in aqueous two-phase systems. KONDO, A., KANEKO, T., and HIGASHITANI, K., Appl. Microbiol. Biotechnol., 1993, 441, (2-3), 365–369.
  • Uptake of zinc(II)-phthalocyanine by HepG2 cells expressing the low density lipoprotein receptor: Studies with the liposomal formulation CGP55847. LOVE, W. G., HAVENAAR, E. C., LOWE, P. J., and TAYLOR, P. W., Proc. SPIE-Int. Soc. Opt. Eng., 1994,2078, (Photodynamic therapy of Cancer), 381–388.
  • CGP 55 847, lipsome-delivered zinc-(11)-phthalocyanine as a phototherapeutic agent for tumors. SCHIEWECK, K., CAPRARO, H. G., IsELE, U., VAN HOOGEVEST, P., OCHSNER, M., MAURER, T., and BATT, E.., Proc. SPIE-Int. Soc. Opt. Eng., 1994, 2078, (Photodynamic Therapy of Cancer), 107–118.
  • Microwave-induced lipid peroxidation in liposomes. BABINCOVA, M., Folio Biol. (Prague), 1993, 39, (5), 250–255.
  • Photosensitive liposomes. BENNETT, D. E., LAMPARSKI, H., and O'BRIEN, D. F., Liposome Res., 1994, 331–348.
  • The potentially for tm elevation of dipalmitoylphosphatidylcholine liposomes. FERNANDEZ, M. S., Be,. Bunsen-Ges. Phys. Chem., 1994, 98, (4), 592–595.
  • Differential scanning calorimetry study on the binding of nucleic acids to dimyristoylphos-phatidylcholine-sphingosine liposomes. Koiv, A., MUSTONEN, P., and KINNCNEN, P. K. J., Chem. Phys. Lipids, 1994, 70, (1), 1–10.
  • Unusual low proton permeability of liposomes prepared from the endogenous myelin lipids. DIAZ, R. S., and MONREAl„ J.,.7. Neurochem., 1994, 62, (5), 2022–2029.
  • Interaction of tocopherol with peroxyl radicals does not lead to the formation of lipid hydroperoxides in liposomes. DMITRIEV, L. F., IVANOVA, M. V., and LANKIN, V. Z., Chem. Phys. Lipids, 1994, 69, (1), 35–39.
  • Increased gene expression after liposome-mediated arterial gene transfer associated with intimal smooth muscle cell proliferation in vitro and in vivo findings in a rabbit model of vascular injury. TAKESHITA, S. GAL, D., LECLERC, G., PICKERING, J. G., RIESSEN, R., WEIR, L., and ISNER, J. M., y. Clin. Invest., 1994, 93, (2), 652–661.
  • Effect of membrane surface potential on the uptake of anionic compounds by liposomes. SUGAWARA, M., HASHIMOTO, A., KOBAYASHI, M., ISEKI, K., and MIYAZAKI, K., Biochim. Biophys. Acta, 1994, 1192, (2), 241–246.
  • The oxidation of uranium monocarbide microspheres. MUKERJEE, S. K., RAMA, R. G. A., DEHADRAYA, J. V., VAIDYA, V. N., VENUGOPAL, V., and SOOD, D. D., I. Nucl. Mater., 1994, 210, (1-2), 97–106.
  • High-performance liquid chromatographic determination of mitoxantrone in liposome preparations using solid-phase extraction and its application in stability studies. LAw, S. L., and JANG, T. F., y. Chromatogr. A, 1994, 670, (1-2), 234–238.
  • Conference Proceedings The Liposome Conference in Saint Petersburg: New Concepts, Perspectives, and Clinical Applications,' June 9–11.1993, Saint Petersburg, Russia. In: y.
  • Liposome Res., 1994, 4, (1). ALLEN, T. M., DAEMEN, T., FICHTNER, I., KIKUCHI, H., LASCH, J., LESERMAN, L., Liu, D., MARUYAMA, K., and RAHMAN, A., et al. (New York: Dekker), 739 pp. Study on polyamide microcapsules containing oily liquids. YAN, N., ZHANG, M., and Ni, P., y. Microencapsulation, 1994, 11, (4), 365–372.
  • Spray-dried albumin microspheres for the intra-articular delivery of dexamethasone. PAVANETTO, F., GENTA, I., GIUNCHEDI, P., CONTI, B., and CONTE, U., y. Microencapsulation, 1994, 11, (4), 445–454.
  • Preparation of human serum albumin microspheres by a novel acetone-heat denaturation method. CFIEN, C. Q., LiN, W., COOMBES, A. G. A., DAVIS, S. S., and ILLum, L., .7. Microencapsulation, 1994, 11, (4), 395–407.
  • Cellulose acetate butyrate and polycaprolactone for ketoprofen spray-dried microsphere preparation. GIUNCHED I, P., CONT, B., MAGGI, L., and C()NTE, U., y. Microencapsulation, 1994, 11, (4), 381–393.
  • Liposome-induced activation of the classical complement pathway does not require immunoglobulin. MARJAN, J., XIE, Z., and DEVINE, D. V., Biochim. Biophys. Acta, 1994, 1192, (1), 35–44.
  • Microencapsulation of vitamin A. TORRADO, S., TORRADO, J. J., FRUTOS, G., and CADORNIGA, Y. R., An. R. Acad. Farm., 1993, 59, (1), 109–119.
  • Microencapsulation of theophylline. EL SAYED, A. M., SAVED, H. A. M., OSMAN, A. H., and FATHY, M., Bull. Pharm. Sci., Assiut. Univ., 1993, 16, (2), 113–123.
  • Dose and load studies for subcutaneous and oral delivery of poly (lactide-co-glycolide) microspheres containing ovalbumin. UCHIDA, T., MARTIN, S., FOSTER, T. P., WARDLEY, R. C., and GRIMM, S., Pharm. Res., 1994, 11, (7), 1009–1015.
  • Development and evaluation of controlled-release diclofenac microspheres and tabletted microspheres. VILIVALAM, V. D., and ADEYEYE, C. M., J. Microencapsulation, 1994, 11, (4), 455–470.
  • Pressurized pack-based liposomes for pulmonary targeting of isoprenaline. Development and characterization. VYAS, S. P., and SAKTHIVEL, T., J. Microencapsulation, 1994, 11, (4), 373–380.
  • Interactions of liposome bilayers composed of 1,2-diacy1-3-succinylglycerol with protons and divalent cations. TARI, A. M., FULLER, N., BONI, L. T., COLLINS, D. RAND, P., and HUANG, L., Biochim. Biophys. Acta, 1994, 1192, (2), 253–262.
  • Pharmacokinetics and tissue distribution of methotrexate after intravenous injection of differently charged liposome-entrapped methotrexate to rats. KIM, C. K., LEE, M. K., HAN, J. H., and LEE, B. J., Int. J. Pharm., 1994, 108, (1), 21–29.
  • Permeability and stability in buffer and in human serum of fluorinated phospholipid-based liposomes. FREZARD, F. SANTAELLA, C., VIERLING, P., and RIESS, J. G., Biochim. Biophys. Acta, 1994, 1192, (1), 61–70.
  • Why do polyethylene glycol-coated liposomes cieculate so long? Molecular mechanism of liposome steric protection with polyethylene glycol: role of polymer chain flexibility. TORCHILIN, V. P., and PAPISOV, M. I., J. Liposome Res., 1994, 725–739.
  • Biodistribution and antitumor effect of adriamycin encapsulated in long-circulating liposomes containing amphipathic polyethylene glycol or ganglioside GMI. MARUYAMA, K., OKAMOTO, A., ISHIDA, O., KOJIMA, S., SUGINAKA, A., HUANG, L., and IWATSURU, M., 7. Liposome Res., 1994, 701–723.
  • The use of transmembrane pH gradient-driven drug encapsulation in the pharmacodynamic evaluation of liposomal doxorubicin. MAYER, L. D., CuLus, P. R., and BALLY, M. B., 7. Liposome Res., 1994, 529–553.
  • Stability of acrylic resin nifedipine microspheres. SILVA, B. O., HIKAL, A. H., CLEARY, R. W., JONES, A. B., and DAVIS, W. M., Drugs Made Ger., 1993, 36, (4), 137–138.
  • Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. HARAN, G., COHEN, R., BAR, L. K., and BARENHOLZ, Y., Biochim. Biophys. Acta, 1994, 1190, (1), 197.
  • Antibody-targeted liposomes to deliver doxorubicin to ovariari cancer cells. STORM, G., NASSANDER, U. K., VINGERHOEDS, M. H., STEERENBERG, P. A., and CROMMELIN, D. J. A., 7. Liposome Res., 1994, 641–666.
  • Release of active drug from intracellular liposomal prodrug depots in macrophages controlled by liposome composition. SHERPHOF, GERRIT, L., and WAALKES, M. V. B., 7. Liposome Res., 1994, 427–437.
  • Enzyme-controlled release with liposomes. Liu, p., 7. Liposome Res., 1994, 413–425.
  • Preparation and characteristics of microcapsules containing water-absorbent polymer. TANAKA, M., SATO, H., KIMURA, I., and SAITO, N., Shikizai Kyokaishi, 1993, 66, (8), 449–460.
  • Aggregation behaviour of core-shell type polymer microspheres. IsHtzu, K., NARUSE, F., and SAITO, R., Polymer, 1994, 35, (11), 2329–2334.
  • Effect of surface morphology on electrostatic property of polymer microsphere. HATATE, Y HIGO, S., UEMURA, Y., KAWANO, Y., IDE, S., HATANAKA-CHIAKI, and HARAGUCHI-TOSHINOBU., Kagoshima Daigaku Kogakubu Kenkyu Hokoku, 1994, 35, 39–45.
  • Polymeric liposomes: preparation, characterization and applications. KOBAYASHI, S. and UYAMA, H., Pol. y. Chem., 1994, 68, (3), 417–444.
  • Encapsulation of Agrobacterium Ti plasmid into liposomes. PARK, J. S., PARK, H. J., and KIM, I. S., Korean Biochem. 7., 1994, -27, (3), 190–195.
  • Characterization of antigen-coupled liposomes for homogeneous immunoassay of polyclonal antibodies. TOMIOKA, K., FUKUDA, H., and KATOH, S., Chem. Eng. y. (Lausanne), 1994, 54,(2), 33B–9B.
  • Cell surface distribution of high-avidity LFA-1 detected by soluble ICAM-1-coated micro-spheres. PSYZNIAK, A. M., WELDER, C. A., and TAKEI, F., 7. Immunol., 1994, 152, (11), 5241–5249.
  • Liposomes, muramyl dipeptide derivatives, and nontoxic lipid A derivatives as adjuvants for human malaria vaccines. Hut, G. S. N., Am. 7. Trop. Med. Hyg., 1994,50, (4, Suppl.), 41–51.
  • The properties of liposomes obtained with the help of Polysorb-1. LAGUTINA, L. S., MAMAEV, D. V., and SHOLTZ, K. F., Biol. Membr., 1994, 11, (1), 80–88.
  • Liposome-administered tetramethylhematoporphyrin (TMHP) as a photodynamic agent. REICH, E., BACHOR, R., MILLER, K., KOENIG, K., REPASSY, D., and HAUTMANN, R., Proc. SPIE-Int. .So r opt. Eng., 1994, 2078, (Photodynamic Therapy of Cancer), 229–239.
  • Immobilization of gamma-glutamyl transpeptidase, a membrane enzyme, in gel beads via liposome entrapment. GOTOH, T., SHIDARA, M., I WANAGA, T., KIKUCHI, K., and HOZAWA, M., 7. Ferment. Bioeng., 1994, 77, (3), 268–273.
  • Potent and reversible interaction of silver with pure Na, K-ATPase and Na, K-ATPase-lipo-somes. HUSSAIN, S., MENEGHINI, E., MOOSMAYER, M., LACOTTE, D., and ANNER, B. M., Biochim. Biophys. Acta, 1994, 1190, (2), 402–408.
  • Liposomes containing purine and pyrimidine bases: stable unilamellar liposomes from phosphatidyl nucleosides. BONACCIO, S., WALDE, P., and LuIst, P. L., J. Phys. Chem., 1994, 98, (26), 6661–6663.
  • Fusion of phospholipid vesicles induced by clathrin: modulation of fused liposome size. YOSHIMURA, T., MAEZAWA, S., KAMEYAMA, K., and TAKAGI, T., y. Biochem. (Tokyo), 1994, 115, (4), 715–723.
  • Analysis of the antimetastatic effects of synthetic muramyl tripeptide (CGP 19835A) encapsulated in liposomes in combination with other immunomodulatory agents and chemotherapeutic drugs. BEZAULT, J., WALSH, C., TARCSAY, L., FROST, H., LIEBES, L., and FURMANSKI, P., In Vivo, 1993, 7, (6A), 487–491.
  • Processing of pyrimidine nucleosides by Kupffer cells in vitro effects of lipophilic derivatization and incorporation in liposomes. VAN BORSSUM, W. M., and SCHERPHOF, G. L., Cells Hepatic Sinusoid, 1993, 4, 544–547.
  • Effect of liposomal lipids on the activation of liver macrophages to tumor cytotoxicity. DAEMEN, T., REGTS, J., and SCHERPHOF, G. L., Cells Hepatic Sinusoid, 1993, 4, 504–507.
  • Effect of elimination of phagocytic cells by liposomal dichloromethylene diphosphonate on aspergillosis virulence and toxicity of liposomal amphotericin B in mice. MOONIS, M., AI-MAD, I., and BACHHAWAT, K., J. Antimicrob. Chemother., 1994, 33, 571–583.
  • Molecular and cellular studies of hyaluronic acid-modified liposomes as bioadhesive carriers for topical drug delivery in wound healing. YERSHALMI, N., ARAD, A., and MARGALIT, R., Arch. Biochem. Biophys., 1994, 313, (2), 267–273.
  • Cardiac output and regional blood flow measurement with nonradioactive microspheres by X-ray fluorescence spectrometry in rats. KUWAHIRA, I., MORI, H., MOUE, Y., SHINOZAKI, Y., OHTA, Y., YAMABAYASHI, H., OKINO, H., GONZALEZ, N. C., HEISLER, N., and PIIPER, J., Adv. Exp. Med. Biol., 1994, 345, 877–884.
  • The function of phagocytosing cells from irradiated mice immunized with the liposomal form of Pseudomonas aeruginosa anatoxin. MINUKHIN, V. V., BRODINOVA, N. S. TSYGANENKO, A., TKACHENKO, V. L., IVANOVA, N. N., and VASI-CHENKO, V. N., Zh. Mikrobiol. Epidemiol. Immunobiol., 1993, (6), 79–81.
  • The immunogenic properties of the liposomal form of Pseudomonas aeruginosa anatoxin in burned and irradiated mice. MINUKHIN, V. V., BRODINOVA, N. S., TSYGANENKO, A., TKACHENKO, V. L., IVANOVA, N. N., and VASIL-CHENKO, V. N., Zh. Mikrobiol. Epidemiol. Immunobiol., 1993, (6), 69–71.
  • Chemoembolization with mitomycin C microcapsules (MMC-mc) in the treatment of bone metastases from prostatic and renal cancer. KAKINUMA, H., SATO, K., MIURA, K., SASAKI, S., and KATO, T., Nippon Hinyokika Gakkai Zasshi, 1994, 85, (7), 1116–1123.
  • Liposomal amphotericin B, AmBisome. HAY, R. J., y. Infect., 1994, 28, Suppl. 1, 35–43.
  • Activation of human neutrophils by Arg-Gly-Asp-Ser immobilized on microspheres. KASUYA, Y., FUJIMOTO, K., MIYAMOTO, M., and KAWAGUCHI, H., J. Biomed. Mater. Res., 1994, 28, (3), 397–404.
  • Significance of amino groups of phosphatidylethanolamine in phospholipid peroxidation of mixed liposomes. WANG, J. Y., WANG, Z. Y., KOUYAMA,SHIBATA, T., and UEKi, T., Chem.Phi's. Lipids., 1994, 71, (2), 197–203.
  • Activation of phospholipase A2 in 1-palmitoy1-2-oleoyl-sn-glycero-3-phosphocholine lipo-somes containing lipid ozonation products. SALGO, M. G., SQUADRITO, G. L., and PRYOR, W. A., Chem. Res. Toxicol., 1994, 7, (3), 458–462.
  • Changes in the lipid dynamics of liposomal membranes induced by poly (ethylene glycol): free volume alterations revealed by inter- and intramolecular excimer-forming phospholipid analogs. Biophys. y., 1994, 66, (66), 1981–1990.
  • Flurorinated phosphatidylcholine-based liposomes: H + /Ns + permeability, active doxoru-bicin encapsulation and stability, in human serum. FREZARD, F., SANTAELLA, C., MONTISCI, M. J., VIERLING, P., and RIESS, J. G., Biochim. Biophys. Acta, 1994, 1194, (1), 61–68.
  • Liposome targeting to human immunodeficiency virus type 1-infected cells via recombinant soluble CD4 and CD4 immunoadhesin (CD4-IgG). FLASHER, D., KONOPKA, K., CHAMOW, S. M., DAZIN, P., ASHKENAZI, A., PRETZER, E., and DUZGUNES, N., Biochim. Biophys. Acta, 1994, 1194, (1), 185–196.
  • Solubililzation by Triton X-100 makes possible complete recovery of lipids from liposomes in enzymatic assay. NAGAYASU, A., SHIMOOKA, T., and KIWADA, H., Biochim. Biophys. Acta, 1994, 1194, (1), 12–16.
  • Fast-protein liquid chromatography system as a tool for liposome preparation by the extrusion procedure. TURANEK, J., Anal. Biochem., 1994, 218, (2), 352–357.
  • The effect of the peroxidation of ribamidil-containing liposomes on the results of chemo-therapy in experimental viral infections. KHAMITOV, R. A., GRABAREVA, L. P., PSHENICH-NOV, V. A., and ERESKINA, O. A., Vopr. Viruso/., 1993, 38, (1), 21–24.
  • Photodynamic therapy of human bladder carcinoma cells in vitro with pH-sensitive liposomes as carriers for 9-acetoxy-tetra-n-propylporphycene. AictiER, A., MILLER, K., REICH, E., and HAUTMANN, R., Urol. Res., 1994, 22, (1), 25–32.
  • Arterial microsphere concentrations in cats are not affected by changes in hematocrit. DEWITT, D. S. PROUGH, D. S., DEAL, D. D., and HOEN, H. M., Stroke, 1994, 25, (9), 1842–1846.
  • Anaphylactic reactions to liposomal amphotericin (letter). LAING, R. B., MILNE, L. J., LEEN, C. L., MALCOLM, G. P., and STEERS, A. J., Lancet, 1994, 344, (8923), 682.
  • In vitro and in vivo evaluation of thyrotrophin releasing hormone release from copoly(dl-lac-tic/glycolic acid) microspheres. HEYA, T., OKADA, H., OGAWA, Y., and TOGUCHI, H., J. Pharm. Sci., 1994, 83, (5), 636–640.
  • Use of technetium-99m-liposomes in tumor imaging. GoiNs, B., KLIPPER, R., RUDOI,PH, A. S., and PHILLIPS, W. T., y. Nucl. Med., 1994, 35, (9), 1491–1498.
  • The use of lipsomes in the investigation of mechanisms of asbestos damage. ERDOGDU, G., and HASIRCI, V. N., Experientia, 1994, 50, (8), 785–787.
  • Pharmacokinetic behaviour and antineoplastic activity of liposomal hexadecylphospho-choline. KAUFMANN, K. P., DREVS, J., BERGER, M. R., KOTTING, J., MARSCHNER, N., UNGER, C., and EIBL, H., Cancer Chemother. Pharmacol., 1994, 34, (5), 393–398.
  • Microsphere absorption by the nasal mucosa of the rat. ALPAR, H. O., ALMEIDA, A. J., and BROWN, M. R., J. Drug. Target, 1994, 2, (2), 147–149.
  • The complement- bu not mannose receptor-mediated phagocytosis is involved in the hepatic uptake of cetylmannoside-modified liposomes in situ. MATsuc), H., FCNATO, K., HARASHIMA, H., and KIWADA, H., J. Drug Target, 1994, 2, (2), 141–146.
  • Fat soluble vitamins in liposomes: studies on incorporation efficiency and bile salt induced vesicle disintegration. KIRILENKO, V. N., and GREGORIADIS, G., J. Drug. Target, 1993, 1, (4), 361–368.
  • Distribution within the organs of a reticuloendothelial system of liposomes containing lipid A. PARK, Y. S., and HUANG, L., y. Drug. Target, 1993, 1, (4), 325–330.
  • Activity of liposomal amphotericin B (AmBisome) against Leishmania infantum and tissue distribution in mice. GRADONI, L., DAVIDSON, R. N., ORSINI, S., BETTO, P., and GIAMBENEDETTI, M., y. Drug Target, 1993, 1, (4), 311–316.
  • Liposomal (MLV) polymyxin B: physicochemical characterization and effect of surface charge and drug association. LAWRENCE, S. M., ALPAR, H. O., MCALLISTER, S. M., and BROWN, M. R., J. Drug. Target, 1993, 1, (4), 303–310.
  • Application of lipid microspheres to prepare a thromboxane A2 receptor antagonist aerosol for inhalation. TAKENAGA, M., NAKAGAWA, T., IGARASHI, R., and MIZUSHIMA, Y., J. Drug Target, 1993, 1, (4), 293–301.
  • Enhanced tumor targeting of doxorubicin by ganglioside GM1-bearing long-circulating liposomes. UNEZAKI, S., MARUYAMA, K., ISHIDA, O., TAKAHASHI, N., and IWATSURIZ, NI., J. Drug. Target, 1993, 1, (4), 287–292.
  • Comparison of poly(DI-lactide-co-glycolide) and polystyrene microsphere targeting to intestinal M cells. JEPSON, NI. A., SIMMONS, N. L., O'HAGAN, D. T., and HIRsT, B. H., J. Drug Target, 1993, 1, (3), 245–249.
  • Efficient entrapment of amikacin and teicoplanin in liposomes. RAVAOARINORO, NI., Tom, E., AGBABA, O., and MORISSET, R., J. Drug Target, 1993, 1, (3), 191–195.
  • Review: recent advances in lipid microsphere technology for targeting prostaglandin delivery. MIZUSHIMA, Y., and HOSHI, K., J. Drug Target, 1993, 1, (2), 93–100.
  • Mannosylated liposomes as carriers for hamycin in the treatment of experimental aspergillo-sis in Balb/C mice. MooN18, M., AIIMAD, I., and BACHHAWAT, B. K., y. Drug Target, 1993, 1, (2), 147–155.
  • Targeting anticancer drugs to the brain. I: Enhanced brain delivery of oxantrazole following administration in magnetic cationic microspheres. HASSAN, E. E., and GALLO, J. Ni., J. Drug Target, 1993, 1, (1), 7–14.
  • Lipsomes, a tale of drug targeting (editorial). GREGORIADIS, G., J. Drug Target, 1993, 1, (1), 3–6.
  • Tissue distribution and cellular distribution of liposomes encapsulating muramyltripeptide phosphatidyl ethanolamide. Tissue and cellular distribution of LE-MTPPE. MELISSEN, P. NI., VAN VIANEN, W., LEENEN, P. J., and BAKKER-WOUDENBERG, I. A., Biotherapy, 1993, 7, (1), 71–78.
  • Pharmacokinetics and immunomodulatory effects on monocytes during prolonged therapy with liposomal muramyltripeptide. LANDMANN, R., OBRIST, R., DENZ, H., LUDWIG, C., FROST, H., WESP, M. RORDORF, C., TOWBIN, H., GYGAX, D., and TARCSAY, L. etal., Biotherapy, 1993, 7, (1), 1–12.
  • Liposome encapsulation circumvents the hepatic clearance mechanisms of all-trans-retinoic acid. MEHTA, K., SADEGHI, T., MCQUEEN, T., and LOPEZ, B. G., Leuk.sRes., 1994, 18, (8), 587–596.
  • A study of complement fixation test by trinitropheyl-cap-liposome: application of viral antibody test. YAMAUCHI, T., YAmAmoTo, Y., SAWAYANAGI, Y., HUKUSHIMA, M., H iKIZI, K., UEDA, M., and MASAKI, T., Rinsho Byori, 1994, 42, (7), 737–742.
  • Sustained-release dosage form of phenylpropanolamine hydrochloride. Part II: Formulation and in vitro release kinetics from tableted microcapsules. Sevci, F., OZYAZICI, M., and GUNERI, T., J. Microencapsul., 1994, 11, (3), 335–344.
  • Sustained-release dosage form of phenylpropanolamine hydrochloride. Part I: Microencapsu-lation and in vitro release kinetics. SEVGI, F., OZYAZICI, M., and GUNERI, T., Microencapsul., 1994, 11, (3), 327–334.
  • Effect of the solvent-non-solvent pairs on the surface morphology and release behaviour of ethylcellulose microcapsules prepared by non-solvent-addition phase separation method. Wu, J. C., Su, S. G., SHYC, S. S., and CHEN,Microencapsul., 1994, 11, (3), 297–308.
  • Chemotherapy targeting regional lymph nodes by gastric submucosal injection of liposomal adriamycin in patients with gastric carcinoma. AKAMO, Y., MizuNO, I., YOTSUYANAGI, T., lum No, T., TANIMOTO, N., YAmAmoTo, T., NAGATA, M., TAKEYAMA, H., SHINAGAWA, N., and YURA, J. et al., jpn. y. Cancer Res., 1994, 85, (6), 652–658.
  • Bioavailability of microsphere-entrapped cyclosporine A in the cornea and aqueous of rabbits. HARPER, C. A. III, KHOOBEHI, B., PEYMAN, G. A., GERHARDT, B. M., and DUNLAP, W. A., Int. Ophthalmol., 1993-1994, 17, (6), 337–340.
  • Evaluation of the one-point microcapsule agglutination test for diagnosis of leptospirosis. ARIMITSU, Y., KNIETY, E., ANANYINA, Y., BARANTON, G., FERGUSON, I. R., SNMEHE, L., and TERPSTRA, W. J., Bull. World Health Organ, 1994, 72, (3), 395–399.
  • Secretion pattern of the rat liver macrophage population following activation with liposomal muramyl dipeptide in vivo and in vitro. HOEDEMAKERS, R. M., MoRsELT, H. W., SCHERPHOF, G. L., and DAEMAN,Immunother. Emphasis Tumor Immunol.,. 1994, 15, (4),265–272.
  • Contrast-enhanced MR imaging of diffuse and focal splenic disease with use of magnetic starch microspheres. KREFT, B. P., TANIMOTO, A., LEFFLER, S., FINN, J. P., OKSENDAL, A. N., and STARK, D. D.,.7. Magn. Reson. Imaging, 1994, 4, (3), 373–379.
  • Transformation of wheat protoplasts mediated by cationic liposome and regeneration of transgenic plantlets. ZHU, Z., SUN, B., LIU, C. XIAO, G., and Li, X., Chin, y. Biotechnol., 1993, 9, (4), 257–261.
  • Absorption of liposome-encapsulated tetracaine versus nonliposome-encapsulated tetracaine from open wounds in rabbits. FISHER, R. MURPHY, M., HUNG, O., MEZEI, NI., and STEWART, R., Am. 1. Emerg. Med., 1994, 12, (5), 521–523.
  • Liposomes in the combined treatment of patients with chronic obstructive bronchitis. NOVIKOVA, R. I., CHERNYI, V. I., STEFANOV, A. V., and AKHLAMOVA, 1., Ter. Arkh., 1993, 65,(3), 40–43.
  • Differential disposition of soluble and liposome-formulated human recombinant interleukin-7: effects on blood lymphocyte population in guinea pigs. Bui, T., FALTYNEK, C., and Ho, R. J., Pharm. Res., 1994, 11, (5), 633–641.
  • Development and evaluation of sustained-release ibuprofen-wax microspheres. II. In vitro dissolution studies. A i) EvEYE, C. M., and PRICE, J. C., Pharm. Res., 1994, 11, (4), 575–579.
  • Activation of Fe receptor-mediated phagocytosis by mouse peritoneal macrophages following the intraperitoneal administration of liposomes. ARAMAKI, Y., MURAI, M., and 'FsuctilYA, S., Pharm. Res., 1994, 11, (4), 518–521.
  • Preparation of agglomerated crystals for direct tabletting and microencapsulation by the spherical crystallization technique with a continuous system. NIWA, T., TAKEUCHI, H., HIND, T., IToH, A., KAWASHIMA, Y., and KIUCHI, K., Pharm. Res., 1994, 11, (4), 478–484.
  • Effect of liposomal entrapping on anaphylactic properties of allergens. Apo, A. D., FEDOSEEVA, V. N., SEREBRENNIKOVA, G. A., GOLDSHTEIN, M. M., SHUSTOVA, V. I., AVDEEVA, T. A., KRAVCIIENKO, S. A., and USHAKOVA, 1. P., Patol. Fiziol. Eksp. Ter., 1993, (2), 3–5.
  • Characterization of human immunodeficiency virus type I gp120 binding to liposome containing galactosylceramide. LONG, D., BERSON, J. F., COOK, D. G., and Doms, R. W., J. Virol., 1994, 68, (9), 5890–5898.
  • Treatment of candiduria with liposomal amphotericin B (L-AmpB-LRC) in children (letter). GOKHALE, P. C., KSHIRSAGAR, N. A., KHAN, M. U., PANDYA, S. K., MERCHANT, R. H., MEHTA, K. P., and COLACO, M. P., J. Antimicrob. Chemother., 1994, 33, (4), 889–891.
  • Prevention of corneal allograft rejection in rats treated with subconjunctival injections of liposomes containing dichloromethylene diphosphonate. VAN DER VEEN, G., BROERSMA, L., DIJKSTRA, C. D., VAN ROOIJEN, N., VAN Rij, G., and VAN DER GAAG, R., Invest. Ophthalmol. Vis. Sci., 1994, 35, (9), 3505–3515.
  • In vitro phagocytosis of polylactide microspheres by retinal pigment epithelial cells and intracellular drug release. KIMURA, H., OGURA, Y., MORITERA, T., HONDA, Y., TABATA, Y., and IKADA, Y., Curr. Eye. Res., 1994, 13, (5), 353–360.
  • A new method to measure bilayer thickness: cryo-electron microscopy of frozen hydrated liposomes and image simulation. TAHARA, Y., and FUJIYOSHI, Y., Micron, 1994, 25, (2), 141–149.
  • Liposomes from mammalian liver mitochondria are more polyunsaturated and leakier to protons than those from reptiles. BRAND, M. D., COUTURE, P., and HULBERT, A. J., Comp. Biochem. Physiol. Biochem. Mol. Biol., 1994, 108, (2), 181–188.
  • Inclusion of ganglioside GM1 into liposome encapsulated hemoglobin does not extend circulation persistence at clinically relevant doses. GOINS, B., LIGLER, F. Sand RI:DOLPH, A. S., Arti f. Cells Blood Substit. Immobil. Biotechnol., 1994, 22, (1), 9–25.
  • Stability and proton-permeability of liposomes composed of archaeal tetraether lipids. ELFERINK, M. G., DE WIT, J. G., DRIESSEN, A. J., and KONINGS, W. N., Biochim. Biophys. Acta, 1994, 1193, (2), 247–254.
  • Tumor-localizing properties of porphyrins. In vitro studies using the porphyrin precursor, aminolevulinic acid, in free, and liposome encapsulated forms. FulCUDA, H., PAREDES, S., and BATLLE, A. M., Drug. Des. Deliv., 1989, 5, (2), 133–139.
  • Quantitative determination of phosphatidylethanolamine and phosphatidylserine in lipo-somes and on HPTLC plates with ophthalaldehyde. ZELLMER, S., and LASCH, J., Anal. Biochem., 1994, 218, (1), 229–281.
  • Steric immobilization of liposomes in chromatographic gel beads and incorporation of integral membrane proteins into their lipid bilayers. YANG, Q., and LUNDAHL, P., Anal. Biochem., 1994, 218, (1), 210–221.
  • Liposomes in medicine. An assessment of current status. PRUFER, K., and STERNBERG, B., Z. Arztl. Fortbild, (Jena), 1994, 88, (4), 257–260.
  • A novel application of microsphere perfusion and scanning electron microscopy to the identification of pulmonary arterioles in guinea-pig and rabbit lungs. WALKER, D. C., HOSFORD, S., and MACKENZIE, A., J. Microsc., 1994, 174, (Pt 2), 111–119.
  • A lipophilic complex with 186Re/188Re incorporated in liposomes suitable for radiotherapy. HAFELI, U., TIEFENAUER, L. X., SCHBIGER, P. A., and WEDER, H. G., Int. J. Rad. Appl. B., 1991, 18, (5), 449–454.
  • Therapeutic effect of adriamycin encapsulated in long-circulating liposomes on Meth-A-sar-coma-bearing mice. OKU, N., Doi, K., NAMBA, Y., and OKADA, S., Int..7. Cancer, 1994,58, (3), 415–419.
  • Free and microencapsulated adrenal cortical cells produce similar cortisol responses when stimulated by ACTH: an in vitro study. ABOBAKR, A. M., Int. J. Artif. Organs, 1994, 17, (3), 171–174.
  • Clustering of vitronectin and RGD peptides on microspheres leads to engagement of integrins on the luminal aspect of endothelial cell membrane. ZANETTI, A., CONFORTI, G., HESS, S., MARTIN, P. 1., GHIBAUDI, E., PREISNER, K. T., and DEJANA, E, 1994, Blood, 1994, 84, (4), 1116–1123.
  • pH sensitive liposomes composed of tocopherol hemisuccinate and of phosphatidyl-ethanolamine including tocopherol hemisuccinate. JIZOMO'FO, H., KANAOKA, E., and HIRANO, K., Biochim. Biophys. Acta, 1994, 1213, (3), 343–348.
  • Liposomal amphotericin B in hepatic candidosis. SHARLAND, M., HAY, R. J., and DAVIES, E. G. Arch. Dis. Child, 1994, 70, (6), 546–547.
  • The mosquitocidal efficacy of microcapsules of alpha-cypermethrin against Anopheles sinensis. PAN, K. Y., YE, B. H., and ZHI, C. L., Chung Kuo Chi Sheng Chung Hsueh Yu Chi Sheng Chung Ping Tsa Chih, 1994, 12, (1), 40–42.
  • The effect of high pressure on induced lipid peroxidation processes in liposome membranes. VDOVIN, A. V., TIURIN, K. A., and VANDYSFIEV, D. B., Biokhimiia, 1994, 59, (5), 720–725.
  • The effect of cholesterol level in liposomes on the interaction with blood serum lipoproteins. ZAKHAROVA, T. S., IVANOV, A. S., ECHKALOV, A. P., BEREZOV, A. T., KHALII0V, E. M., and ARCHAKOV, A. I., Biokhimiia, 1994, 59, (5), 712–719.
  • Selected tissue distribution of liposomal methylprednisolone in rats. MISHINA, E. V., and JuSKO, W. J., Res. Commun. Chem. Pathol. Pharmacol., 1994, 84, (1), 47–52.
  • Beneficial effects of myristic, stearic or oleic acid as part of liposomes on experimental infection and antitumor effect in a murine model. GALDIERO, F., CARRATELLI, C. R., Nuzzo, I., BENTIVOGLIO, C., DE MARTINO, L., GORGA, F., FOLGORE, A., and GALDIERO, M., Life-Sci., 1994, 55, (7), 499–509.
  • Interaction between zinc(II)-phthalocyanine-containing liposomes and human low density lipoprotein. VERSLUIS, A. J., RENSEN, P. C., KUIPERS, M. E., LOVE, W. G., and TAYLOR, P. w., J. Photochem. Photobiol. B., 1994, 23, (2-3), 141–148.
  • Liposomal anthracyclines. GABIZON, A. A., Hematol. Oncol. Clin. North. Am, 1994,8, (2), 431–450.
  • Effect of elimination of phagocytic cells by liposomal dichloromethylene diphosphonate on aspergillosis virulence and toxicity of liposomal amphotericin B in mice. MOONIS, M., AHMAD, I., and BACHHAWAT, B. K., J. Antimicrob. Chemother., 1994, 33, (3), 571–583.
  • Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy. NING, S., MACLEOD, K., ABRA, R. M., HUANG, A. H., and HAHN, G. M., Int. J. Radiat. Oncol. Biol. Phys., 1994, 29, (4), 827–834.
  • Lipid chain order and dynamics at different bilayer depths in liposomes of several phosphatidylcholines studied by differential polarized phase fluorescence. TRICERRI, M. A., GARDA, H. A., and BRENNER, R. R., Chem. Phys. Lipids., 1994, 71, (1), 61–72.
  • Lack of an immune response to Albunex, a new ultrasound contrast agent based on air-filled albumin microspheres. CHRIS'TIANSEN, C., VERNER, A. J., MUAN, B., VIK, H., HAIDER, T., NICOLAYSEN, H., and SKOTLAND, T., Int. Arch. Allergy Immunol., 1994, 104, (4), 372–378.
  • Another case report of rhinocerebral mucormycosis treated with liposomal amphotericin B and surgery (letter). LINI, K. K., Purrs, M. J., WARNOCK, D. W., IBRAHIM, N. B., BROWN, E. M., and BURNS, C. C., Clin. Infect. Dis., 1994, 18, (4), 653–654.
  • Inactivation of free and liposome-encapsulated aminoglycosides by enzymes of resistant strains of bacteria. BELIAVSKAIA, I. V., GRIAZNOVA, N. S., AFONIN, V. I., PETIUSHENKO, R. M., SAZYKIN, I., and NAVASHIN, S. M., Antibiot. Khimioter., 1993, 38, (8-9), 26–29.
  • Successful treatment of resistant visceral leishmaniasis with liposomal amphotericin B. GoR HALE, P. C., KSHIRSAGAR, N. A., KHAN, M. C., PANDYA, S. K., MEISHERI, Y. V., THAKUR, C. P., and CHOUDHARY, C. B., Trans. R. Soc. Trop. Med. Hyg., 1994, 88, (2), 228. Introduction of hepatitis delta virus into animal cell lines via cationic liposomes. BICHKO, V., NETTER, H. J., and TAYLOR, JVirol., 1994, 68, (8), 5247–5252.
  • Effects of naftifrofuryl oxalate on microsphere embolism-induced decrease in regional blood flow of rat brain. MIYAKE, K., TAKAGI, N., and TAKEO, S., Br. J. Pharmacol., 1994, 112, (1), 226–230.
  • Tumor cell binding and induction of endothelial cell tumoricidal activity in vitro by muramyl dipeptide is enhanced by liposomal encapsulation. PHILLIPS, N. C., STEWART, P. J., and WANG, P., I. Immunother. Emphasis Tumor Immunol., 1994, 15, (3), 185–193.
  • Fusion of influenza to liposomes is not inhibited by aliphatic primary alcohols. LENIAY, C. T., CECCARELLI, D. F., and EPAND, R. M., Biosii. Rep., 1994, 14, (1), 33–42.
  • Physical and biochemical characterization of Albunex, a new ultrasound contrast agent consisting of air-filled albumin microspheres suspended in a solution of human albumin. CHRISTIANSEN, C., KRYVI, H., SONTUNI, P. C., and SKOTLAND, T ., Biotechnol. Appl. Biochern., 1994, 19, (pt 3), 307–320.
  • Interactions of the pyrethroid insecticide allethrin with liposomes. MOYA, Q. NI. R., MUNOZ, D. E., and VIDAL, C. J., Arch. Biochem. Biophys., 1994, 312, (1), 95–100.
  • Pharmacokinetics and safety of a unilamellar lipsomal formulation of amphotericin B (AmBisome) in rabbits. LEE, J. W., ANIANTEA, M. A., FRANCIS, P. A., NAVARRO, E. E., BACHER, J., Pizzo, P. A., and WALSH, T. J., Antimicrob. Agents Chemother., 1994,38, (4), 713–718.
  • Effects of host genetic background and microencapsulation on survival of rat-to-mouse islet xenografts. WEBER, C., TANNA, A., COSTANZO, M., AYRES, P. J., PETERSON, L., and WICKER, L., Transplant Proc., 1994, 26, (3), 1186–1188.
  • NOD mouse peritoneal cellular response to poly-L-lysine-alginate microencapsulated rat islets. WEBER, C., AYRES, P. J., CosTAtizo, NI., BECKER, A., and STALL, A., Transplant-Proc., 1994, 26, (3), 1116–1119.
  • Normalization of diabetes in cynomolgus monkeys by xenotransplantation of microencapsu-lated porcine islets. ZHOU, D., SUN, Y. L., MA, P., and SUN, A. M., Transplant Proc., 1994, 26, (3), 1091.
  • The antimicrobial action of a liposomal preparation lipin. NASR, A. N., Mikrobiol. Z., 1993, 55, (6), 62–66.
  • Liposomal delivery of methylphosphonate antisense oligodeoxynucleotides in chronic myelogenous leukemia. TARI, A. NI., TUCKER, S. D., DEISSEROTH, A., and LOPEZ, B. G., Blood, 1994, 84, (2), 601–607.
  • Receptor-mediated gene transfer into hepatic cells using asialoglycoprotein-labeled lipo-somes. KOIKE, K., HARA, T., ARAMAKI, Y., TAKADA, S., and TSUCHIYA, S., Ann. N. Y. Acad. Sci., 1994, 716, 331–333.
  • Cationic liposomes for direct gene transfer in therapy of cancer and other diseases. FARHOOD, H., GAO, X., SON, K., YANG, Y. Y., LAzo, J. S., HUANG, L., BARSOUM, J., BOTTEGA, R., and EPAND, R. M., Ann. N. Y. Acad. Sci., 1994, 716, 23–34; (discussion) 34–35.
  • Depletion of serum iron levels in rats by intravenous administration of liposome-encapsulated desferrioxamine. TABAK, A., and HOFFER, E., Acta Haematol., 1994, 91, (2), 111-113.Effect of MTP-PE liposomes and interleu.kin-7 on induction of antibody and cell-mediated immune responses to a recombination HIV-envelope protein. But, T., DYKERS, T., Hu, S. L., FAI.TYNEK, C. R., and Ho, R. J., J. Acquir. Immune Defic. Syndr., 1994, 7, (8), 799–806.
  • Intrahepatic portal occlusion by microspheres: a new model of portal hypertension in the rat. JAFFE, V., ALEXANDER, B., and MATHIE, R. T., Gut, 1994, 35, (6), 815–818.
  • Sustained release of phenytoin following the oral administration of phenytoin sodium/ethyl-cellulose microcapsules in human subjects and rabbits. KARAKASA, I., YAGI, N., SHIBATA, M., KENMOTSU, H., SEKIKAWA, H., and TAKADA, M., Biol. Pharm. Bull., 1994, 17,(3), 432–436.
  • Amphotericin B-induced nephrogenic diabetes insipidus: resolution with its liposomal counterpart (letter). SMITH, O. P., GALE, R., HAMON, M., MCWHINNEY, P., and PRENTICE, H. G., Bone Marrow Transplant, 1994, 13, (1), 107–108.
  • Novel Taxol formulations: Taxol-containing liposomes. STRAUBINGER, R. M., SHARNIA, A., MURRAY, M., and MAYHEW, E., Monogr. Natl. Cancer Inst., 1993, (15), 69–78.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.